Teladoc Health (TDOC) Expected to Announce Earnings on Wednesday

Teladoc Health (NYSE:TDOC) is projected to issue its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect Teladoc Health to post earnings of ($0.19) per share and revenue of $635.3290 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, February 25, 2026 at 5:00 PM ET.

Teladoc Health Stock Down 2.2%

TDOC stock opened at $4.55 on Wednesday. The firm has a market cap of $807.49 million, a price-to-earnings ratio of -3.55 and a beta of 2.12. Teladoc Health has a 1-year low of $4.40 and a 1-year high of $14.61. The firm has a fifty day moving average price of $6.40 and a two-hundred day moving average price of $7.32. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60.

Wall Street Analyst Weigh In

A number of equities analysts have commented on TDOC shares. Weiss Ratings restated a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 29th. Bank of America cut their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 25th. Citigroup cut their target price on Teladoc Health from $10.00 to $9.00 and set a “neutral” rating for the company in a research report on Friday, January 9th. Barclays initiated coverage on shares of Teladoc Health in a report on Tuesday, December 9th. They issued an “equal weight” rating and a $8.50 target price on the stock. Finally, Evercore decreased their target price on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a report on Thursday, October 30th. Three equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $9.12.

Insider Activity

In other Teladoc Health news, CEO Charles Divita III sold 17,138 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $7.63, for a total value of $130,762.94. Following the transaction, the chief executive officer owned 201,036 shares of the company’s stock, valued at approximately $1,533,904.68. The trade was a 7.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,209 shares of the firm’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 33,288 shares of company stock worth $251,684. 0.58% of the stock is currently owned by insiders.

Institutional Trading of Teladoc Health

Several hedge funds and other institutional investors have recently modified their holdings of TDOC. Syon Capital LLC grew its position in shares of Teladoc Health by 19.1% during the 4th quarter. Syon Capital LLC now owns 14,140 shares of the health services provider’s stock worth $99,000 after purchasing an additional 2,264 shares in the last quarter. HighTower Advisors LLC lifted its position in shares of Teladoc Health by 19.2% during the 4th quarter. HighTower Advisors LLC now owns 18,647 shares of the health services provider’s stock worth $131,000 after buying an additional 2,997 shares during the last quarter. Polymer Capital Management US LLC bought a new position in shares of Teladoc Health in the third quarter worth about $131,000. Entropy Technologies LP acquired a new stake in Teladoc Health in the third quarter valued at approximately $133,000. Finally, Quantitative Investment Management LLC grew its position in Teladoc Health by 40.3% during the 3rd quarter. Quantitative Investment Management LLC now owns 17,799 shares of the health services provider’s stock worth $137,000 after acquiring an additional 5,114 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.